Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$5.28 - $18.9 $94,754 - $339,179
-17,946 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$12.92 - $27.18 $231,862 - $487,772
17,946 New
17,946 $315,000
Q3 2021

Nov 12, 2021

SELL
$41.3 - $54.56 $615,535 - $813,162
-14,904 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$38.61 - $55.0 $575,443 - $819,720
14,904 New
14,904 $809,000
Q1 2021

May 14, 2021

SELL
$38.1 - $59.09 $267,385 - $414,693
-7,018 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$33.26 - $59.72 $233,418 - $419,114
7,018 New
7,018 $305,000

Others Institutions Holding ACCD

About Accolade, Inc.


  • Ticker ACCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 71,938,896
  • Market Cap $258M
  • Description
  • Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...
More about ACCD
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.